Iranian Journal of Neurology 2017. 16(2):90-95.

Prevalence of familial multiple sclerosis in Iran: A systematic review and meta-analysis
Mahmood Moosazadeh, Ravanbakhsh Esmaeili, Mohammad Mehdi Nasehi, Ghasem Abedi, Mahdi Afshari, Fereshteh Farshidi, Motahareh Kheradmand

Abstract


Background: Familial history of multiple sclerosis (MS) has been considered as one of the etiologic factors of MS by several studies. It is valuable to combine the results of these studies. The aim of this study is to estimate the pooled prevalence of familial MS in Iran using meta-analysis.

Methods: Using relevant keywords, national and international databanks were searched. Considering the significant heterogeneity between the results, random effect model was utilized to estimate the pooled prevalence of familial MS using Stata software.

Results: After screening the selected articles,
15 studies with total sample size of 6248 (from 60 to 1718) were identified eligible for final
meta-analysis. Overall prevalence of familial MS in Iran was estimated as of 11.4% [95% confidence interval (CI): 8.7-14.1]. Point prevalence varied between 3.3% and 26.7%.

Conclusion: Our study showed that the familial prevalence of MS among Iranian people is relatively high. More studies are warranted to investigate the effect of familial history as a risk factor for MS.

Keywords


Familial; Multiple Sclerosis; Meta-Analysis; Prevalence; Iran

Full Text:

PDF

References


Files DK, Jausurawong T, Katrajian R and Danoff R. Multiple sclerosis. Primary care. 2015; 42: 159-75.

Esposito F, Guaschino C, Sorosina M, et al. Impact of MS genetic loci on familial aggregation, clinical phenotype, and disease prediction. Neurology(R) neuroimmunology & neuroinflammation. 2015; 2: e129.

Mansouri B, Asadollahi S, Heidari K, et al. Risk factors for increased multiple sclerosis susceptibility in the Iranian population. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 2014; 21: 2207-11.

Hollenbach JA and Oksenberg JR. The immunogenetics of multiple sclerosis: A comprehensive review. Journal of autoimmunity. 2015; 64: 13-25.

Nielsen NM, Westergaard T, Rostgaard K, et al. Familial risk of multiple sclerosis: a nationwide cohort study. American journal of epidemiology. 2005; 162: 774-8.

Marrosu M, Lai M, Cocco E, et al. Genetic factors and the founder effect explain familial MS in Sardinia. Neurology. 2002; 58: 283-8.

Kahana E. Epidemiologic studies of multiple sclerosis: a review. Biomedicine & pharmacotherapy. 2000; 54: 100-2.

Carton H, Vlietinck R, Debruyne J, et al. Risks of multiple sclerosis in relatives of patients in Flanders, Belgium. Journal of Neurology, Neurosurgery & Psychiatry. 1997; 62: 329-33.

Ebers G, Koopman W, Hader W, et al. The natural history of multiple sclerosis: a geographically based study. Brain. 2000; 123: 641-9.

Hader WJ and Yee IM. The prevalence of familial multiple sclerosis in saskatoon, Saskatchewan. Multiple sclerosis international. 2014; 2014.

Hashemilar M, Savadi Ouskui D, Farhoudi M, Ayromlou H and Asadollahi A. Multiple sclerosis in East-Azerbaijan, north west Iran. Neurology Asia. 2011; 16: 127-31.

Etemadifar M and Abtahi S-H. Multiple Sclerosis in Isfahan: past, present and future. International journal of preventive medicine. 2012; 3.

Moosazadeh M, Nekoei‐moghadam M, Emrani Z and Amiresmaili M. Prevalence of unwanted pregnancy in Iran: a systematic review and meta‐analysis. The International journal of health planning and management. 2014; 29: e277-e90.

Von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Preventive medicine. 2007; 45: 247-51.

Ashtari F, Shaygannejad V, Heidari F and Akbari M. Prevalence of Familial Multiple Sclerosis in Isfahan, Iran. Journal of Isfahan Medical School. 2011; 29.

Baghizadeh S, Sahraian MA and Beladimoghadam N. Clinical and demographic factors affecting disease severity in patients with multiple sclerosis. Iranian journal of neurology. 2013; 12: 1.

Danesh-Sani SA, Rahimdoost A, Soltani M, Ghiyasi M, Haghdoost N and Sabzali-Zanjankhah S. Clinical assessment of orofacial manifestations in 500 patients with multiple sclerosis. Journal of Oral and Maxillofacial Surgery. 2013; 71: 290-4.

Ghabaae M and Roostaeizadeh M. Epidemiology of multiple sclerosis in Tehran: a three year study. Tehran University Medical Journal (TUMJ). 2007; 65: 74-7.

Mazaheri S FM, Hossainzadeh A. Evaluation of clinical and epidemiologic features of patients with multiple sclerosis with early onset and comparison with the beginning of puberty. Yafteh. 2007; 9: 39-44. [In persian]

Payamani.F MM. Survey of Symptoms and Side Effects in Patients With Multiple Sclerosis. Mandish 2011; 2: 45-50. [In persian]

Pourmemari M, Rabie S, Bagheri H, Taghilo G and Eskandari F. Epidemiologic variables in multiple sclerosis patients in ZANJAN. Journal of Nursing and Midwifery Faculties Guilan Medical University 2011; 21: 1-6. [In persian]

Rezaali S, Khalilnezhad A, Moghadasi AN, Chaibakhsh S and Sahraian MA. Epidemiology of multiple sclerosis in Qom: Demographic study in Iran. Iranian journal of neurology. 2013; 12: 136-43.

A.A. R and M.S P. Descriptive cross Sectional Study of Clinical Manifestation and MRI Finding in 60 Multiple Sclerosis Patients Scientific Journal of Hamedan university of Medical Sciences and Health Services 2005; 12: 53-6. [In persian]

Saadatnia M, Etemadifar M and Maghzi AH. Multiple sclerosis in Isfahan, Iran. International review of neurobiology. 2007; 79: 357-75.

Taraghi Z, Ilali E, Abedini M, et al. Quality of life among multiple sclerosis patients. Iran Journal of Nursing. 2007; 20: 51-9. [In persian]

Kalanie H, Gharagozli K and Kalanie AR. Multiple sclerosis: report on 200 cases from Iran. Multiple sclerosis. 2003; 9: 36-8.

Saman-Nezhad B, Rezaee T, Bostani A, Najafi F and Aghaei A. Epidemiological characteristics of patients with multiple sclerosis in Kermanshah, Iran in 2012. J Mazandaran Univ Med Sci. 2013; 23: 97-101.

El-Salem K, Al-Shimmery E, Horany K, Al-Refai A, Al-Hayk K and Khader Y. Multiple sclerosis in Jordan: a clinical and epidemiological study. Journal of neurology. 2006; 253: 1210-6.

Nagy Z, Bencsik K, Rajda C, et al. Epidemiology of familial multiple sclerosis in Hungary. Multiple Sclerosis. 2007.

Willer CJ, Dyment DA, Cherny S, et al. A genome-wide scan in forty large pedigrees with multiple sclerosis. Journal of human genetics. 2007; 52: 955-62.


Refbacks

  • There are currently no refbacks.


Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.